usnic acid has been researched along with Invasiveness, Neoplasm in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " KU showed increased bioavailability compared with UA in the tumor, liver, and plasma of a CT26 syngeneic mouse tumor xenograft model after oral administration, as determined by LC-MS/MS analysis." | 5.48 | Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. ( Bae, WK; Choi, YJ; Chung, IJ; Gamage, C; Ha, HH; Hur, JS; Kim, H; Kim, KK; Kim, SK; Lee, JH; Lee, JY; Lee, KH; Paik, MJ; Park, MS; Park, SY; Taş, İ; Yang, Y; Yu, YH; Zhou, R, 2018) |
| " KU showed increased bioavailability compared with UA in the tumor, liver, and plasma of a CT26 syngeneic mouse tumor xenograft model after oral administration, as determined by LC-MS/MS analysis." | 1.48 | Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. ( Bae, WK; Choi, YJ; Chung, IJ; Gamage, C; Ha, HH; Hur, JS; Kim, H; Kim, KK; Kim, SK; Lee, JH; Lee, JY; Lee, KH; Paik, MJ; Park, MS; Park, SY; Taş, İ; Yang, Y; Yu, YH; Zhou, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 2 |
| Bae, WK | 1 |
| Lee, JY | 1 |
| Choi, YJ | 1 |
| Lee, KH | 1 |
| Park, MS | 1 |
| Yu, YH | 2 |
| Park, SY | 1 |
| Zhou, R | 1 |
| Taş, İ | 1 |
| Gamage, C | 1 |
| Paik, MJ | 1 |
| Lee, JH | 1 |
| Chung, IJ | 1 |
| Kim, KK | 2 |
| Hur, JS | 2 |
| Kim, SK | 1 |
| Ha, HH | 2 |
| Kim, H | 2 |
| Nguyen, TT | 1 |
| Jeong, MH | 1 |
| Crişan, F | 1 |
| Choi, KH | 1 |
| Jeong, HG | 1 |
| Jeong, TC | 1 |
| Lee, KY | 1 |
2 other studies available for usnic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzofurans; Biological Availability; Cell Lin | 2018 |
Inhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell Motility.
Topics: Antineoplastic Agents; Benzofurans; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; | 2016 |